Evaluation of Activity Levels, Inflammatory Markers, and Overall Wellness.

NCT ID: NCT03619265

Last Updated: 2020-03-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-17

Study Completion Date

2020-02-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose for this protocol is to perform a double-blind, randomized, placebo-controlled, parallel-arm clinical study in healthy subjects to evaluate the efficacy of a nutraceutical product on physical and mental energy levels and overall wellness.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Range of Motion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A double-blinded, randomized, placebo-controlled, parallel-arm clinical study design will be used.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Prickly pear juice

Prickly pear juice, 3 oz daily for 8 weeks.

Group Type EXPERIMENTAL

Prickly pear juice

Intervention Type DIETARY_SUPPLEMENT

3 ounces daily for 8 weeks.

Pear-flavored juice

Pear-flavored juice, 3 oz daily for 8 weeks.

Group Type PLACEBO_COMPARATOR

Pear-flavored juice

Intervention Type DIETARY_SUPPLEMENT

3 ounces daily for 8 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Prickly pear juice

3 ounces daily for 8 weeks.

Intervention Type DIETARY_SUPPLEMENT

Pear-flavored juice

3 ounces daily for 8 weeks.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy adults of either gender;
* 35-75 years old;
* Chronic joint/muscle related pain for at least past 6 months;
* Body mass index (BMI) at or below 34.9 kg/m2.

Exclusion Criteria

* Bariatric surgery;
* Diagnosed with diabetes Type I;
* Taking medication for diabetes Type II;
* Known serious chronic health condition;
* Serious active illness within past 12 months;
* Major surgery within the past 3 months;
* Major trauma within the past 3 months;
* Alcohol consumption of more than four standard units/day (for example more than four regular 12 oz beers (5% alcohol), four small 5-oz glasses of wine (12% alcohol), or four 1.5 oz shots of 80-proof spirits), or more than 28 units per week;
* Daily consumption of Nopalea or similar juice products during the past month;
* Currently taking anti-inflammatory nutritional supplements judged by the study coordinator to negate or camouflage the effects of the test product;
* Taking anti-inflammatory medications on a daily basis (81 mg aspirin is acceptable);
* Use of oral, inhaled or injected steroid medication within the last 6 months (for example: prednisone, dexamethasone). Nasal sprays for allergies are allowed;
* Any other significant disease or disorder that the investigator judges may put the subject at risk because of participation in the study, or may influence the result of the study;
* Any other condition or observation that the investigator judges may adversely affect the person's ability to complete the study;
* Women of child-bearing potential: Pregnant, breast-feeding, or trying to become pregnant;
* Known allergies to ingredients in the test and placebo products.
Minimum Eligible Age

35 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Natural Immune Systems Inc

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gitte Jensen

Role: PRINCIPAL_INVESTIGATOR

NIS Labs

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

NIS Labs

Klamath Falls, Oregon, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS114012

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Acute Effects on Stem Cell Surveillance
NCT07341178 NOT_YET_RECRUITING NA